These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


142 related items for PubMed ID: 2149548

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The effect of prazosin therapy on platelet activation in essential hypertension.
    Okrucká A, Pechán J, Mikulecký M.
    Clin Exp Pharmacol Physiol; 1990 Dec; 17(12):813-9. PubMed ID: 2151184
    [Abstract] [Full Text] [Related]

  • 3. Effects of prazosin on platelet aggregation and plasma beta-thromboglobulin in essential hypertension.
    Ikeda T, Nonaka Y, Goto A, Ishii M.
    Clin Pharmacol Ther; 1985 Jun; 37(6):601-5. PubMed ID: 2408807
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Hemorheologic changes in patients with essential hypertension treated with prazosin].
    Gerc V, Koblar V, Brkić D, Kamhi J.
    Med Pregl; 1992 Jun; 45(7-8):285-7. PubMed ID: 1344459
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Platelet function and fibrinolytic activity in hypertension: differential effects of calcium antagonists and beta-adrenergic receptor blockers.
    Winther K, Gleerup G, Hedner T.
    J Cardiovasc Pharmacol; 1991 Jun; 18 Suppl 9():S41-4. PubMed ID: 1725542
    [Abstract] [Full Text] [Related]

  • 10. Plasma concentrations of platelet-specific proteins in different stages of essential hypertension: interactions between platelet aggregation, blood lipids and age.
    Yamanishi J, Sano H, Saito K, Furuta Y, Fukuzaki H.
    Thromb Haemost; 1985 Aug 30; 54(2):539-43. PubMed ID: 2417354
    [Abstract] [Full Text] [Related]

  • 11. [Platelet aggregation in whole blood with the impedance method in subjects with non-complicated essential arterial hypertension].
    Craveri A, Lanfredini M, Casati R, Citella C.
    Minerva Med; 1988 Jun 30; 79(6):441-6. PubMed ID: 2967926
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effect of oestrogen dose on whole blood platelet activation in women taking new low dose oral contraceptives.
    Norris LA, Bonnar J.
    Thromb Haemost; 1994 Dec 30; 72(6):926-30. PubMed ID: 7740465
    [Abstract] [Full Text] [Related]

  • 14. Effects of adrenaline infusion on serum thromboxane B2 and plasma beta-thromboglobulin levels in hypertensive and normotensive subjects.
    Douma S, Zamboulis C, Karagiannis A, Sinakos Z.
    Nouv Rev Fr Hematol (1978); 1992 Dec 30; 34(1):73-8. PubMed ID: 1387933
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The effect of short-term celiprolol therapy on platelet function in essential hypertension.
    Okrucká A, Pechán J, Balazovjech I.
    Cardiology; 1993 Dec 30; 82(6):399-404. PubMed ID: 8402762
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Diltiazem inhibits the spontaneous platelet aggregation in essential hypertension.
    Pechán J, Okrucká A.
    Cardiology; 1991 Dec 30; 79(2):116-9. PubMed ID: 1834333
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.